Selcia is a leading provider of integrated drug discovery services, specializing in 14C custom radiolabeling for metabolism, environmental fate, and human ADME studies. They offer a range of services including medicinal chemistry, assay development and screening, PPIase services, and structural elucidation. With a focus on pharmaceutical, biotechnology companies, and academic institutions, Selcia provides high-quality solutions for drug discovery and development.
With expertise in 14C GMP API, Selcia offers custom synthesis and radiolabeling services for clinical trials registration studies. They also excel in chemistry analytics, providing GLP characterizations of process impurity, degradation products, and metabolites. With a strong commitment to quality and innovation, Selcia is a trusted partner in the field of drug discovery and research.
Generated from the website